Funds · PCRX

Who owns PCRX?

Institutional ownership of Pacira BioSciences Inc. from Form 13F, Q2 2026

253 institutional managers reported holding Pacira BioSciences Inc. (PCRX) in Form 13F filings for Q2 2026, with 43,987,120 shares worth $1.1B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 619,111 shares (+1.4%). 37 opened new positions and 24 sold out.

Funds holding
253
Value held
$1.1B
New / sold out
37 / 24
Net shares, same filers
+1.4%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of PCRX

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$170M15.2%6,705,809Trimmed
Doma Perpetual Capital Management LLC$70.5M6.3%2,777,794Unchanged
Vanguard Portfolio Management LLC$61.0M5.5%2,406,238Trimmed
Dimensional Fund Advisors LP$53.4M4.8%2,103,245Added
State Street Corp$52.3M4.7%2,059,977Added
D. E. Shaw & Co., Inc.$49.5M4.4%1,950,332Trimmed
Renaissance Technologies LLC$44.0M3.9%1,733,801Trimmed
Vanguard Capital Management LLC$42.9M3.8%1,691,571Trimmed
Goldman Sachs Group Inc$38.7M3.5%1,527,129Trimmed
Geode Capital Management, LLC$29.4M2.6%1,158,693Added
Morgan Stanley$29.0M2.6%1,144,654Trimmed
American Century Companies Inc$25.8M2.3%1,018,093Added
UBS Group AG$23.3M2.1%920,217Added
Impax Asset Management Group plc$19.0M1.7%750,027Unchanged
Two Sigma Investments, LP$18.4M1.6%724,604Added
Charles Schwab Investment Management Inc$17.5M1.6%690,786Trimmed
Gagnon Securities LLC$15.4M1.4%608,617Trimmed
LSV Asset Management$15.4M1.4%608,376Added
Wellington Management Group LLP$14.3M1.3%563,458Added
Northern Trust Corp$13.4M1.2%526,782Added
Bridgeway Capital Management, LLC$10.4M0.9%411,373Unchanged
Deutsche Bank Ag\$9.9M0.9%391,101Trimmed
Jefferies Financial Group Inc.$9.4M0.8%370,092Added
Hillsdale Investment Management Inc.$9.2M0.8%362,700Added
Gagnon Advisors, LLC$8.9M0.8%352,637Unchanged

Share of 13F holdings is each fund's shares as a share of the 43,987,120 PCRX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $92.1M and sold $74.6M; 80 added and 83 trimmed.

Schedule 13D and 13G filings on PCRX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about PCRX ownership

Who owns PCRX stock?
253 institutional investment managers reported PCRX positions in their Form 13F filings for Q2 2026, holding 43,987,120 shares worth $1.1B in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling PCRX?
In Q2 2026, 37 managers opened new PCRX positions, 80 added, 83 trimmed and 24 sold out. Managers that filed in both quarters added a net 619,111 shares.
How current is this PCRX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PCRX by CUSIP. Options are left out. PCRX news and filings · PCRX insider trades · Top funds